Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

References

• LacroJPDunnLBDolderCRLeckbandSGJesteDVPrevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literatureJ Clin Psychiatry2002631089290912416599
   PubMed Web of Science ®Google Scholar
• Ascher-SvanumHFariesDEZhuBErnstFRSwartzMSSwansonJWMedication adherence and long-term functional outcomes in the treatment of schizophrenia in usual careJ Clin Psychiatry200667345346016649833
   PubMed Web of Science ®Google Scholar
• NovickDHaroJMSuarezDPerezVDittmannRWHaddadPMPredictors and clinical consequences of non-adherence with anti-psychotic medication in the outpatient treatment of schizophreniaPsychiatry Res20101762–310911320185182
   PubMed Web of Science ®Google Scholar
• Alvarez-JimenezMPriedeAHetrickSERisk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studiesSchizophr Res20121391–311612822658527
   PubMed Web of Science ®Google Scholar
• MacfaddenWMaYWThomas HaskinsJBossieCAAlphsLA prospective study comparing the long-term effectiveness of injectable risperidone long-acting therapy and oral aripiprazole in patients with schizophreniaPsychiatry20107112331
   Google Scholar
• RosenheckRAKrystalJHLewRLong-acting risperidone and oral antipsychotics in unstable schizophreniaN Engl J Med2011364984285121366475
   PubMed Web of Science ®Google Scholar
• PietriniFD’AnnaGTatiniLChanges in attitude towards LAI antipsychotic maintenance treatment: a two-year follow-up studyEur Psychiatry201853586529957369
   PubMed Web of Science ®Google Scholar
• KishimotoTHagiKNittaMEffectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: a meta-analysis of prospective and retrospective cohort studiesSchizophr Bull201844360361929868849
   PubMed Web of Science ®Google Scholar
• CheungSHamuroYMahlichJNakaharaTSruamsiriRTsukazawaSDrug utilization of Japanese patients diagnosed with schizophrenia: an administrative database analysisClin Drug Investig2017376559569
   Web of Science ®Google Scholar
• KishimotoTSanghaniSRussMJIndications for and use of long-acting injectable antipsychotics: consideration from an inpatient settingInt Clin Psychopharmacol201732316116828181959
   PubMed Web of Science ®Google Scholar
• JaegerMRosslerWAttitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatristsPsychiatry Res20101751–2586220004980
   PubMed Web of Science ®Google Scholar
• TsangHWFongMWFungKMChungRCPerceptions on efficacy and side effects of conventional depot antipsychotics (CDA) and atypical depot antipsychotics (ADA): psychiatrists versus patients in Hong KongInt J Psychiatry Clin Pract2010141233224917229
   PubMed Web of Science ®Google Scholar
• FujiiYIwataNTakahashiKLarge-scale about psychiatrists’ use, knowledge and attitudes to depot antipsychotics: a comparison between Japanese and German psychiatristJpn J Clin Psychpharmacol201215797810
   Google Scholar
• PatelMXde ZoysaNBernadtMBindmanJDavidASAre depot antipsychotics more coercive than tablets? The patient’s perspectiveJ Psychopharmacol201024101483148919304865
   PubMed Web of Science ®Google Scholar
• FourrierAGasquetIAllicarMPBouhassiraMLépineJPBégaudBPatterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatristsBr J Clin Pharmacol2000491808610606841
   PubMed Web of Science ®Google Scholar
• BarnesTRShingleton-SmithAPatonCAntipsychotic long-acting injections: prescribing practice in the UKBr J Psychiatry Suppl200952s37s4219880915
   PubMedGoogle Scholar
• WilliamsRKopalaLMallaASmithGLoveLBalshawRMedication decisions and clinical outcomes in the Canadian national outcomes measurement study in schizophreniaActa Psychiatrica Scandinavica2006113s4301221
   Web of Science ®Google Scholar
• WestJCMarcusSCWilkJCountisLMRegierDAOlfsonMUse of depot antipsychotic medications for medication nonadherence in schizophreniaSchizophr Bull2008345995100118093962
   PubMed Web of Science ®Google Scholar
• InadaTInagakiAPsychotropic dose equivalence in JapanPsychiatry Clin Neurosci201569844044725601291
   PubMed Web of Science ®Google Scholar
• BusnerJTargumSDThe clinical global impressions scale: applying a research tool in clinical practicePsychiatry2007472837
   PubMedGoogle Scholar
• InadaTEvaluation and diagnosis of drug-induced extrapyramidal symptomsYagiGCommentary on the DIEPSS and Guide to Its UsageTokyoSeiwa Publishers19961160
   Google Scholar
• AasIHGuidelines for rating global assessment of functioning (GAF)Ann Gen Psychiatry2011101221251305
   PubMed Web of Science ®Google Scholar
• WareJESherbourneCDThe MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selectionMed Care19923064734831593914
   PubMed Web of Science ®Google Scholar
• TaftCKarlssonJSullivanMDo SF-36 summary component scores accurately summarize subscale scores?Qual Life Res200110539540411763202
   PubMed Web of Science ®Google Scholar
• RosenbergMSociety and the Adolescent Self-ImagePrinceton University PressPrinceton1965
   Google Scholar
• HeresSSchmitzFSLeuchtSPajonkFGThe attitude of patients towards antipsychotic depot treatmentInt Clin Psychopharmacol200722527528217690596
   PubMed Web of Science ®Google Scholar
• KimSWLeeYHJangJEComparison of attitudes toward long-acting injectable antipsychotics among psychiatrists and patientsInt Clin Psychopharmacol2013282808623325306
   PubMed Web of Science ®Google Scholar
• PatelMXde ZoysaNBernadtMDavidASA cross-sectional study of patients’ perspectives on adherence to antipsychotic medication: depot versus oralJ Clin Psychiatry200869101548155619192437
   PubMed Web of Science ®Google Scholar
• PatelMXde ZoysaNBernadtMDavidADepot and oral anti-psychotics: patient preferences and attitudes are not the same thingJ Psychopharmacol200923778979618583438
   PubMed Web of Science ®Google Scholar
• CastleDMorganVJablenskyAAntipsychotic use in Australia: the patients’ perspectiveAust N Z J Psychiatry200236563364112225447
   PubMed Web of Science ®Google Scholar
• RobertsLWGeppertCMEthical use of long-acting medications in the treatment of severe and persistent mental illnessesCompr Psychiatry200445316116715124145
   PubMed Web of Science ®Google Scholar
• IyoMNakagomeKWakamatsuATakahashiKFact-finding survey on awareness and utilization of depot antipsychotics for schizophrenia-results of questionnaire survey of psychiatric nurses and schizophrenia patients in terms of relapse prevention and medicationJap J Psychiatry20141915562
   Google Scholar
• DivacNProstranMJakovcevskiICerovacNSecond-generation antipsychotics and extrapyramidal adverse effectsBiomed Res Int20142014916
   Web of Science ®Google Scholar
• LeuchtSKaneJMKisslingWHamannJEtschelEEngelRRWhat does the PANSS mean?Schizophr Res2005792–323123815982856
   PubMed Web of Science ®Google Scholar
• KirschnerMTheodoridouAFusar-PoliPKaiserSJägerMPatients’ and clinicians’ attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosisTher Adv Psychopharmacol201332899924167680
   PubMedGoogle Scholar